CAS 1903783-48-1

TK216

CAS : 1903783-48-1

TK216 is a potent inhibitor of E26 transformation-specific (ETS) with anticancer activity.

Formule : C₁₉H₁₅Cl₂NO₃

Degré de pureté : 97.22%

Couleur et forme : Solid

Masse moléculaire : 376.23

Ref: TM-T13166

TK216

CAS : 1903783-48-1

TK216

Degré de pureté : ≥95%

Masse moléculaire : 376.23g/mol

Ref: 54-BUP04698

TK216

CAS : 1903783-48-1

TK216 is a monoclonal antibody that binds with high affinity and specificity to the leukocyte antigen CD19. TK216 is a humanized antibody that inhibits cell proliferation by inducing apoptosis, thereby inhibiting tumor growth. This drug targets CD19-expressing cells and has been shown to be effective in vitro as well as in vivo, where it has shown an inhibitory effect on xenograft tumor growth. TK216 has been evaluated in preclinical studies for its potential to treat hematologic malignancies such as leukemia and lymphoma.

Formule : C₁₉H₁₅Cl₂NO₃

Degré de pureté : Min. 95%

Masse moléculaire : 376.2 g/mol

Ref: 3D-DBD78348